| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.333 | 17.738 | 17.379 | 12.467 | 18.680 | 18.141 | 17.174 | 11.600 | 12.831 | 10.878 |
| Total Income - EUR | 17.346 | 17.759 | 17.383 | 12.467 | 18.681 | 18.142 | 17.174 | 11.600 | 12.831 | 10.878 |
| Total Expenses - EUR | 11.763 | 15.686 | 6.223 | 7.092 | 5.354 | 4.474 | 4.537 | 3.877 | 3.994 | 4.784 |
| Gross Profit/Loss - EUR | 5.583 | 2.073 | 11.160 | 5.375 | 13.327 | 13.668 | 12.636 | 7.723 | 8.838 | 6.094 |
| Net Profit/Loss - EUR | 5.063 | 1.541 | 10.629 | 5.001 | 12.767 | 13.161 | 12.131 | 7.382 | 7.581 | 5.231 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Derma Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.348 | 4.129 | 1.941 | 686 | 0 | 0 | 0 | 1.621 | 5.270 | 8.419 |
| Current Assets | 9.111 | 12.651 | 22.127 | 23.345 | 30.891 | 43.414 | 12.387 | 8.670 | 6.996 | 6.000 |
| Inventories | 159 | 247 | 2.274 | 1.030 | 1.571 | 1.597 | 3.215 | 1.078 | 1.295 | 1.512 |
| Receivables | 5.910 | 8.334 | 8.200 | 8.055 | 7.835 | 7.686 | 764 | 5.992 | 21 | 16 |
| Cash | 3.042 | 4.071 | 11.653 | 14.259 | 21.485 | 34.131 | 8.408 | 1.600 | 5.680 | 4.473 |
| Shareholders Funds | 15.324 | 16.708 | 23.771 | 23.608 | 30.668 | 43.248 | 12.180 | 7.431 | 9.036 | 14.217 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 135 | 72 | 297 | 423 | 222 | 166 | 207 | 2.860 | 3.230 | 203 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derma Line Srl